Mednet Logo
Community

What is your approach to CMV prophylaxis in the post-allogeneic stem cell transplant setting?

Are you routinely using letermovir as CMV prophylaxis in high-risk patients? Any special considerations with its use versus other antiviral agents? What is your approach to duration of prophylaxis with any of the above agents?
Community PollStarted

Are you routinely using letermovir in allogeneic stem cell transplant patients?

6 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Virginia School of Medicine
Answered on

We do not routinely use letermovir but we are looking carefully at this data.

We use prophylactic ganciclovir pre transplant and high dose acyclovir post transplant in high risk patients and are reviewing this data as well.

Join for free or sign in to see the full answer